Lymphatic endothelial tumors induced by intraperitoneal injection of incomplete Freund's adjuvant

Experimental Cell Research

Volumn 246, Issue 2, 1999, Pages 368-375

  Mancardi, Sabrina ^a   Stanta, Giorgio ^b   Dusetti, Nelson ^a   Bestagno, Marco ^a   Jussila, Lotta ^c   Zweyer, Marina ^b   Lunazzi, Giancarlo ^a   Dumont, Daniel ^d   Alitalo, Kari ^c   Burrone, Oscar R ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Flt4; Freund's adjuvant; Lymphangioma; Lymphatic endothelium; Tyrosine kinase receptors

Indexed keywords

CD31 ANTIGEN; FREUND ADJUVANT; INTERCELLULAR ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL CULTURE; EXPERIMENTAL NEOPLASM; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHANGIOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY;

ANIMALIA; MURINAE;

EID: 0033080517     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4270     Document Type: Article

References (35)

1. Risau W. Differentiation of endothelium. FASEB J. 9:1995;926-933.
2. Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 267:1992;10931-10934.
3. Folkman J. Tumor angiogenesis. Adv. Cancer Res. 43:1985;175-203.
4. Folkman J., Klagsbrun M. Angiogenic factors. Science. 235:1987;442-447.
5. Joukov V., Pajusola K., Kaipanen A., Chilov D., Lahtinen I., Kukk E., Saksela O., Kalkkinen N., Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15:1996;290-298.
6. Millauer B., Wizigmann-Voos S., Schnürch H., Martinez R., Møller N. P., Risau W., Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 72:1993;835-846.
7. Cotran R. S., Kumar V., Robbins S. L. Pathologic Basis of Disease. 1994;Saunders, Philadelphia. p. 506-512.
8. Heider K., Eustis S. L. Tumors of soft tissue. Tumors of the Mouse. 1994;IARC Scientific, Lyon. p. 611-649.
9. Vecchi A., Garlanda C., Lampugnani M. G., Resnati M., Matteucci C., Stoppacciaro A., Schnurch H., Risau W., Ruco L., Mantovani A., Dejana E. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embrionyc endothelium. Eur. J. Cell Biol. 63:1994;247-254.
10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
11. Sanes J. R., Rubenstein J. L., Nicolas J. F. Use a recombinant retrovirus to study post-implantation cell lineage in mouse embrios. EMBO J. 5:1986;3133-3142.
12. Mallo G. V., Fielder F., Calvo E. L., Ortiz E. M., Vasseur S., Keim V., Morisset G., Iovanna G. L. Cloning ad expression of the p8 cDNA, a new gene activated in pancreas during the active phase of pancreatites, pancreatic development and regeneration and wich promotes cellular growth. J. Biol. Chem. 272:1997;32360-32369.
13. Lacy M. J., Voss E. W. Jr. A modified method to induce immune polyclonal ascites fluid in BALB/c mice using Sp2/0-Ag14 cells. J. Immunol. Methods. 87:1986;169-177.
14. Wagner D. D., Marder V. J. Biosynthesis of von Willebrand protein by human endothelial cells: Processing steps and their intracellular localization. J. Cell Biol. 99:1984;2123-2130.
15. Nicosia R. F. Angiogenesis and the formation of lymphaticlike channels in cultures of thoracic duct. In Vitro Cell Dev. Biol. 23:1987;167-174.
16. Pepper M. S., Wasi S., Ferrara N., Orci L., Montesano R. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells. Exp. Cell. Res. 210:1994;298-305.
17. Quinn T. P., Peters K. G., De Vries C., Ferrara N., Williams L. T. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA. 90:1993;7533-7537.
18. Korhonen J., Polvi A., Partanen J., Alitalo K. The mousetie. Oncogene. 9:1994;395-403.
19. Finnerty H., Kelleher K., Morris G. E., Bean K., Merberg D. M., Kriz R., Morris J. C., Sookdeo H., Turner K. J., Wood C. R. Molecular cloning of murine FLT and FLT4. Oncogene. 8:1993;2293-2298.
20. Dumont D. J., Gradwohl G. J., Fong G.-H., Auerbach R., Breitman M. L. The endothelial-specific receptor tyrosine kinase,tek, Oncogene. 8:1993;1293-1301.
21. Keck P. J., Hauser S. D., Krivi G., Sanzo K., Warren T., Feder J., Connolly D. T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 246:1989;1309-1312.
22. Leung D. W., Cachianes G., Kuang W. J., Goeddel D. V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309.
23. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J. C., Abraham J. A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266:1991;11947-11954.
24. Kaipainen A., Korhonen J., Mustonen T., van Hinsbergh V. W., Fang G.-H., Dumont D., Breitman M., Alitalo K. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA. 92:1995;3566-3570.
25. Pajusola K., Aprelikova O., Armstrong E., Morris S., Alitalo K. Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts. Oncogene. 8:1993;2931-2937.
26. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:1995;27-31.
27. Kwa B. H., Buck R., Nayar J. K., Vickery A. C. Cultured endothelial cells from lymphatics of nude mice parasitized by Brugia malayi. Lymphology. 24:1991;22-25.
28. Bizouarne N., Mitterrand M., Monsigny M., Kieda C. Characterization of membrane sugar-specific receptors in cultured high endothelial cells from mouse peripheral lymph nodes. Biol. Cell. 79:1993;27-35.
29. Witte M. H., Way D. L., Witte C. L., Bernas M. Lymphangiogenesis: Mechanisms, significance and clinical implications. Goldberg I. D., Rosen E. M. Regulation of Angiogenesis. 1997;65-112 Birkhäuser Verlag, Basel.
30. Enzinger F. M., Weiss S. W. Soft Tissue Tumors. 1988;Mosby, St. Louis. p. 625-627.
31. Potter M., Robertson Boyce C. Induction of plasma-cell neoplasms in strain BALB/c mice with mineral oil and mineral oil adjuvants. Nature. 193:1962;1086-1087.
32. Hilleman M. R. Critical appraisal of emulsified oil adjuvants applied to viral vaccines. Prog. Med. Virol. 8:1966;131-182.
33. Kraal G., Schornagel K., Savelkouul H., Muruyama T. Activation of high endothelial venules in peripheral lymph nodes. The involvement of interferon-gamma. Int. Immunol. 6:1994;1195-1201.
34. Schlingemann R. O., Rietveld F. J., Kwaspen F., van de Kerkhof P. C., de Waal R. M., Ruiter D. J. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am. J. Pathol. 138:1991;1335-1347.
35. Jussila, L. Dumont, D. Taipale, J. Fong-Seet, L. Mustonen, T. Alitalo, K.